Retroviral vectors for liver-directed gene therapy

Seminars in Liver Disease

Volumn 19, Issue 1, 1999, Pages 27-37

  Kalpana, Ganjam V ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Gene therapy; Lentiviral vectors; Retroviral vectors

Indexed keywords

CIS ACTING ELEMENT; FUMARYLACETOACETASE; GLUCURONOSYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRANS ACTING FACTOR; VIRUS DNA; VIRUS RNA;

CRIGLER NAJJAR SYNDROME; EXPRESSION VECTOR; FAMILIAL HYPERLIPEMIA; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAHEPATIC CHOLESTASIS; LENTIVIRINAE; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SAFETY; TRANSGENE; TYROSINEMIA; VESICULAR STOMATITIS VIRUS; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0032925803     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007095     Document Type: Review

References (40)

1. Miller AD. Development applications of retroviral vectors. In: Coffin JM, Hughes SH, Varmus HE (eds). Retroviruses. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1997, pp 437-473
2. Wivel NA, Wilson JM. Methods of gene delivery. Hematol Oncol Clin North Am 1998;12:483-501
3. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997;389:239-242
4. Coffin JM, Hughes SH, Varmus HE. Retroviruses 1. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1997
5. Roe T, Reynolds TC, Yu G, et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993;12:2099-2108
6. Anderson WF, McGarrity GJ, Moen RC. Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays. Hum Gene Ther 1993;4:311-321
7. Yee JK, Moores JC, Jolly DJ, et al. Gene expression from transcriptionally disabled retroviral vectors. Proc Natl Acad Sci U S A 1987;84:5197-5201
8. Hawley RG, Covarrubias L, Hawley T, et al. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc Natl Acad Sci U S A 1987;84:2406-2410
9. Yu SF, von Ruden T, Kantoff PW, et al. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A 1986;83:3194-3198
10. Chowdhury JR, Grossman M, Gupta S, et al. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991;254:1802-1805
11. Grossman M, Raper SE, Wilson JM. Towards liver-directed gene therapy: Retrovirus-mediated gene transfer into human hepatocytes. Somatic Cell Mol Genet 1991;17:601-607
12. Raper SE, Wilson JM, Grossman M. Retroviral-mediated gene transfer in human hepatocytes. Surgery 1992;112:333-340
13. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 1980;36:261-268
14. Wilson JM, Jefferson DM, Chowdhury JR, et al. Retrovirus-mediated transduction of adult hepatocytes. Proc Natl Acad Sci U S A 1998;85:3014-3018
15. Grossman M, Raper SE, Kozarsky K, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. [Comments]. Nat Genet 1994;6:335-341
16. Grossman M, Rader DJ, Muller D, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia. Nat Med 1995;1:1148-1154
17. Raper SE, Grossman BS, Rader DJ, et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 1995;223:116-126
18. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation [Comments]. N Engl J Med 1998;338:1422-1426
19. Chowdhury JR, Chowdhury NR, Strom SC, et al. Human hepatocyte transplantation: Gene therapy and more? Pediatrics 1998; 102:647-648
20. Fox IJ, Chowdhury NR, Gupta S, et al. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. Hepatology 1995;21:837-846
21. Tada K, Chowdhury NR, Neufeld D, et al. Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. Liver Transplant Surg 1998;4:78-88
22. Forbes SJ, Themis M, Alison MR, et al. Retroviral gene transfer to the liver in vivo during tri-iodothyronine induced hyperplasia. Gene Ther 1998;5:552-555
23. Kosai KI, Finegold MJ, Thi-Huynh BT, et al. Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. Hum Gene Ther 1998;9:1293-1301
24. Patijn GA, Lieber A, Schowalter DB, et al. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 1998;28:707-716
25. Patijn GA, Lieber A, Meuse L, et al. High-efficiency retrovirus-mediated gene transfer into the livers of mice. Hum Gene Ther 1998;9:1449-1456
26. Burns JC, Friedmann T, Driever W, et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [Comments]. Proc Natl Acad Sci U S A 1993;90:8033-8037
27. Liu ML, Winther BL, Kay MA. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 1996;70: 2497-2502
28. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 1996;93:11400-11406
29. Bukrynsky MI, Haffar OK. HIV-1 nuclear import: Matrix protein is back on center stage, this time together with Vpr. Mol Med 1998; 4:138-143
30. Naldini L, Blomer U, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [Comments]. Science 1996;272:263-267
31. Trono D. HIV accessory proteins: Leading roles for the supporting cast. Cell 1995;82:189-192
32. Cohen EA, Subbramanian RA, Gottlinger HG. Role of auxiliary proteins in retroviral morphogenesis. Curr Top Microbiol Immunol 1996;214:219-235
33. Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997;17:314-317
34. Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol 1997;15:871-875
35. Dull T, Zufferey R, Kelly M, et al. A third generation lentivirus vector with a conditional packaging system. J Virol 1998;72: 8463-8471
36. Miyoshi H, Blomer U, Takahashi M, et al. Development of a self-inactivating lentivirus vector. J Virol 1998;72:8150-8157
37. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentiviral vector for safe and efficient in vivo gene delivery. J Virol 1998;72:9873-9880
38. Davies K, Kalpana G. Integration of retroviruses into a predetermined site. In: Xanthopoulos KG (eds). Gene Therapy. Berlin: Springer-Verlag, 1998, pp 71-76
39. Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc Natl Acad Sci USA 1995;92: 7570-7574
40. Rong L, Gendron K, Bates P. Conversion of a human low-density lipoprotein receptor ligand binding repeat to a virus receptor: Identification of residues important for ligand specificity. Proc Natl Acad Sci U S A 1998;95:8467-8472